 |
| Author | Post |
|---|
Prof Trevor Marshall
Foundation Staff
|
Posted: Wed Feb 9th, 2011 19:37 |
|
Even a short time on antipsychotics may increase the risk of heart disease:
http://www.reuters.com/article/2011/02/09/us-antipsychotics-heart-idUSTRE71871020110209
http://archpsyc.ama-assn.org/cgi/content/abstract/archgenpsychiatry.2011.2v1Foley and her team looked at 25 previous studies that had tracked risk factors for heart disease in patients taking older or newer antipsychotics. These included high blood pressure, cholesterol levels, and body weight.
They found that across all the studies, six to seven of every 10 people on antipsychotics were overweight after six months. Before taking the drugs, only about four of every 10 were overweight, the same as in the general population.
|
jrfoutin
Research Team
| Joined: | Mon Aug 8th, 2005 |
| Location: | Utah USA |
| Posts: | 5004 |
| Status: |
Offline
|
|
Posted: Thu Feb 10th, 2011 08:01 |
|
Interesting. Some might question if anti-psychotics are suppressing or stimulating immune function to favor pathogen success over immune system.
Other studies cite tachycardia, hypertension, arrhythmia and and atherosclerosis as common comorbidities, and we saw that in our Bipolar cohort. There is certainly a link.
Olmesartan is renal protective, but I've often wondered if it wasn't highly cardio-protective as well. Weight returning to healthy levels over time seems to be the MP pattern also (underweight or overweight to norms, as underweight is a huge problem for anorexic hearts as well).
This quote is worth keeping too:
About one in 100 adults in the U.S. has schizophrenia, according to the National Institute of Mental Health.
That would mean that just about everyone knows someone already diagnosed and expected to comply with the standard of care for same.
____________________
Sarcoidosis 125D61, MP10/05 ModP2 12/05 Ph2 6/06 Ph3 10/06, NoIRs limited outings covered, 2/08 25D6.2, 10/08 25D6.9, 7/20 25D<7 1,25D 23.8
|
titta
Health Professional
| Joined: | Tue Jul 3rd, 2007 |
| Location: | United Kingdom |
| Posts: | 306 |
| Status: |
Offline
|
|
Posted: Thu Feb 10th, 2011 11:23 |
|
......on the other hand when those researchers would look at all those lab parameters which change over the course of the MP (in the first 1-2 years for the 'worse' ) they would probably prove using their statistics and old data that you cannot survive on the MP ??
Titta
____________________
MP start Jul'07 | Sarcoidosis
|
Russ
inactive member
|
Posted: Fri Feb 11th, 2011 19:04 |
|
Antipsychotic Drugs May Reduce Brain Tissue Volume:
http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antipsychotic-Drugs-May-Reduce-Brain-Tissue-Volume/ArticleNewsFeed/Article/detail/707553?contextCategoryId=40153
|
titta
Health Professional
| Joined: | Tue Jul 3rd, 2007 |
| Location: | United Kingdom |
| Posts: | 306 |
| Status: |
Offline
|
|
Posted: Sat Feb 12th, 2011 04:39 |
|
Hi Russ,
very interesting study.
The only 'flaw' I can see is that severity of illness is mostly accompanied with more antipsychotic drug 'intake' so I really wonder how they were able to correctly differ these parts.
Nevertheless, the conclusion made, are correct and fit that many neuroleptica have immunsuppressive abilities which palliate the symptoms but do not cure the disease, obviously the opposite.
Imaging a study using the MP is my dream but I see problems regarding acute symptoms which need to be palliated as soon as possible when acute agressions against oneself or others appear. That then would be a theme to discuss and adapt the study design.
Take care,
Titta
____________________
MP start Jul'07 | Sarcoidosis
|
jrfoutin
Research Team
| Joined: | Mon Aug 8th, 2005 |
| Location: | Utah USA |
| Posts: | 5004 |
| Status: |
Offline
|
|
Posted: Sat Feb 12th, 2011 11:06 |
|
I appreciated the researcher's nod to concerns for off-label use for related psych dx.
As general public and professional awareness of % of psych dx comorbid to autoimmune disease (% varies), then studies like this can help medical consumers discuss concerns with their prescribing medical providers.
Abstract here:
http://archpsyc.ama-assn.org/cgi/content/short/68/2/128
Note conclusion:
"...suggesting the importance of careful risk-benefit review of dosage and duration of treatment as well as their off-label use."
Best to all--Janet
____________________
Sarcoidosis 125D61, MP10/05 ModP2 12/05 Ph2 6/06 Ph3 10/06, NoIRs limited outings covered, 2/08 25D6.2, 10/08 25D6.9, 7/20 25D<7 1,25D 23.8
|
titta
Health Professional
| Joined: | Tue Jul 3rd, 2007 |
| Location: | United Kingdom |
| Posts: | 306 |
| Status: |
Offline
|
|
Posted: Sun Feb 13th, 2011 05:05 |
|
Alas, so called modern atypical neuroleptica are very BIG BUSINESS.
Nearly every day you can read a new suggestion to use them in different diseases from anxiety, eating disorder, OCD, autism, neurodermitis, the newest ALS (even their side effects are marketed - becoming fatter might prolong life???? Charite Berlin Neurology).
And I have to admit that esp psychiatrists just follow......(they are those with the most Dollar-connections to industry...).
Titta
____________________
MP start Jul'07 | Sarcoidosis
|
tussilago
inactive member
| Joined: | Thu Dec 17th, 2009 |
| Location: | Sweden |
| Posts: | 223 |
| Status: |
Offline
|
|
Posted: Wed Dec 28th, 2011 05:59 |
|
| After about a year/one and a half year on Quetiapin (Seroquel, anti-psychotic drug) my hearth started to beat really fast an hour or so after I took the medicine in the evening. The psychiatrist I talked to said this can happen. Last edited on Wed Dec 28th, 2011 06:01 by tussilago
____________________
severe neuropsychiatric disease and borrelia antibodies | overwhelmed by symtom in 1996/97 | poor depth perception, dizzy, numb | no vitamin-D tests |Olmesartan since 1st of jan 2010
|
Marysue
Foundation Staff
|
Posted: Thu Dec 29th, 2011 20:19 |
|
When I was very sick pre-MP, my heart would start racing like that in response to certain medications, as well as foods with high D, and even food/drink with high chlorogenic acid.
Now that I am seeing my response to these things diminish over time, my view in hindsight is that as we become increasingly ill, the immune system/body begins to respond in an every increasing "panic" whenever we take something that slows or stops immune activity, particularly via the VDR.
It is as though we are already struggling with the bacteria, but if something shuts down the immune system's ability to respond, our body sets off alarms to tell us we are in even more trouble--and to encourage us not to consume more of that substance or medicaton.
It seems that so many of the medications that alter psychiatric symptoms seem to have a significant effect on immune activity--and pain meds too as we are discussing here:
Understanding the effects of taking Ibuprofen
Marysue
____________________
MP Apr09 (no breaks)| CFS/FM,infert/endometriosis, Autism Spec | hypotension, cardiac IP, chronic muscle/joint pain, severe light sensitivity, sensory/auditory processing | last 25D=12.5 Sep'11
|
Dmitry
Support Team
|
Posted: Tue Oct 20th, 2020 12:23 |
|
https://pubmed.ncbi.nlm.nih.gov/19138716/
There is considerable evidence that schizophrenia is associated with immune system dysregulation. For example, blood and cerebrospinal fluid (CSF) levels of proinflammatory cytokines are significantly increased in schizophrenic patients, and their normalization correlates with improvement in psychotic symptoms. In fact, typical and atypical antipsychotics are reported to modulate immune function in in vitro and in vivo studies. In the present study, we examined the anti-inflammatory effect of antipsychotics, clozapine, olanzapine, risperidone and haloperidol, on serum cytokine levels in lipopolysaccharide (LPS)-treated mice. Atypical antipsychotics, such as clozapine, olanzapine and risperidone, but not haloperidol, suppressed tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, and up-regulated IL-10. Moreover, only clozapine, robustly increased the serum levels of IL-10. Clozapine reproduced its anti-inflammatory feature in polyinsinic-polycytidylic acid sodium salt (Poly[I : C])-induced inflammation. Thus, the anti-inflammatory effect of clozapine would adapt to inflammation induced by some varieties of antigens. Several receptor ligands, such as 8-OH-DPAT, ketanserin, prazosin and scopolamine, were also examined as to their anti-inflammatory effects on serum cytokine levels in LPS-treated mice. Ketanserin and prazosin, but not 8-OH-DPAT nor scopolamine, behaved similarly to atypical antipsychotics. However, the remarkable increase of serum IL-10 level observed in clozapine was not detected in ketanserin and prazosin. These results suggest the unique efficacy of atypical antipsychotics in the suppression of proinflammatory cytokines, and the increase of anti-inflammatory cytokine, IL-10.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897763/
Antipsychotic treatment altered immune function by raising the levels of anti-inflammatory cytokines (IL-4 and IL-10) and suppressing the levels of pro-inflammatory cytokines (IFN-γ).
____________________
MP Sep16 25D17 125D21 | Sep17 25D22 125D27 | May18 25D10 125D29 | heavy brain fog, anxiety, fatigue, depression
|
Current time is 14:16 | |
|
|
|
|
